These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 538114

  • 21. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG, Maksimova NM.
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract] [Full Text] [Related]

  • 22. [Severe complications of tuberculosis in children].
    van Bel F, Hirasing R, van Benthem LH, Wagenaar JP.
    Ned Tijdschr Geneeskd; 1980 Oct 18; 124(42):1767-70. PubMed ID: 6968874
    [No Abstract] [Full Text] [Related]

  • 23. [Immediate results of treatment of children with complicated forms of primary tuberculosis].
    Griko SP.
    Probl Tuberk; 1966 Oct 18; 44(3):33-7. PubMed ID: 5300979
    [No Abstract] [Full Text] [Related]

  • 24. [Hypersensitivity to antituberculous drugs in children].
    Czarnowska B, Rykowska Z, Robakiewicz M, Ciszek J.
    Gruzlica; 1968 Oct 18; 37(1):23-9. PubMed ID: 5305153
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM, Smolenko MI, Romaniuk MD, Slivka IuI.
    Probl Tuberk; 1990 Oct 18; (11):25-8. PubMed ID: 2290809
    [Abstract] [Full Text] [Related]

  • 26. [Symposium: problem of retreated pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979 Oct 18; 2(4):237-40. PubMed ID: 555435
    [No Abstract] [Full Text] [Related]

  • 27. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T.
    Kekkaku; 1980 Jul 18; 55(7):331-9. PubMed ID: 7206413
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of newly detected destructive pulmonary tuberculosis with antibacterial preparations by the maximum concentration limit method].
    Ertli AA, Agkatsev TV, Kozhevnikov SF, Albegov EA.
    Probl Tuberk; 1980 May 18; (5):46-8. PubMed ID: 7384048
    [No Abstract] [Full Text] [Related]

  • 29. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)].
    Kekkaku; 1978 Sep 18; 53(9):471-6. PubMed ID: 713226
    [No Abstract] [Full Text] [Related]

  • 30. Pediatric tuberculosis: problems in diagnosis and issues in management.
    Hilman BC.
    J La State Med Soc; 1998 Dec 18; 150(12):601-10. PubMed ID: 9926699
    [Abstract] [Full Text] [Related]

  • 31. [Results of bronchoscopic examinations of tuberculosis patients undergoing complex chemotherapy].
    Abduraşitova TV.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Dec 18; 30(3):185-8. PubMed ID: 6273992
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of pulmonary tuberculosis in children--a controlled study.
    Dingley HB, Sehgal KL.
    Indian Pediatr; 1974 Apr 18; 11(4):289-95. PubMed ID: 4609235
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
    Morland L.
    Tidsskr Nor Laegeforen; 1990 Nov 20; 110(28):3608-11. PubMed ID: 2260057
    [Abstract] [Full Text] [Related]

  • 34. [Possibilities of resolving cases of chronic pulmonary tuberculosis].
    Mihăilescu P, Plopeanu D, Fonea M, Damian N, Amzărescu E, Mardale C, Moldovan L, Molniceanu I, Zavate T, Baciu A.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983 Nov 20; 32(3):205-14. PubMed ID: 6318293
    [No Abstract] [Full Text] [Related]

  • 35. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R, Piekarniak K, Wyczólkowski M, Martyniak K.
    Pneumonol Pol; 1977 Feb 20; 45(2):125-30. PubMed ID: 840724
    [No Abstract] [Full Text] [Related]

  • 36. [Results of the pilot experiment in short-term anti-tuberculosis chemotherapy].
    Anastasatu C, Bercea O, Corlan E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984 Feb 20; 33(2):135-42. PubMed ID: 6093220
    [No Abstract] [Full Text] [Related]

  • 37. [Tarivid in the combination therapy of patients with pulmonary tuberculosis].
    Koriakin VA, Zeliger LR, Galenko NN.
    Probl Tuberk; 1991 Feb 20; (9):38-40. PubMed ID: 1749755
    [Abstract] [Full Text] [Related]

  • 38. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S, Armas Merino R, Busel I, Baier E, Wolff C, Jabsa Z.
    Rev Med Chil; 1981 Mar 20; 109(3):212-20. PubMed ID: 7280406
    [No Abstract] [Full Text] [Related]

  • 39. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
    Shmelev EI, Stepanian IE.
    Probl Tuberk; 1996 Mar 20; (6):57-60. PubMed ID: 9019774
    [Abstract] [Full Text] [Related]

  • 40. [Tuberculosis].
    Rogowski J.
    Pieleg Polozna; 1982 Mar 20; (1-2):16-7, 24. PubMed ID: 6920784
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.